Longterm complications of COVID19 on the brain are recognised in patients across all age groups and independent of infection severity. Symptoms of such neurological deficits are diverse and include concentration problems, memory lapses, brain scan alterations, and parkinsonism. Called NeuroCOVID, this phenomenon has profound implications, posing unprecedented risks to both society and healthcare systems.

With a multidisciplinary and international consortium of 10 institutions, the EUfunded NeuroCOV project strives to enhance the medical predicaments of developing NeuroCOVID, advance monitoring and treatment, as well as address the societal consequences of this major global problem.

For more information on the project, please visit:
www.neurocov.eu

#NeuroCOVID #LongCOVID #covid19

Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Health and Digital Executive Agency (HaDEA).
Neither the European Union nor the granting authority can be held responsible for them.